Zohar 2009.

Trial name or title	PTSD prevention using escitalopram
Methods	Allocation: randomised Intervention model: parallel assignment Masking: double‐blind (subject, investigator) Primary purpose: prevention
Participants	Ages eligible for study:18 years to 65 years Genders eligible for study: both Accepts healthy volunteers: no
Interventions	Pharmacological intervention: 10 to 20 mg/day of escitalopram versus 1/2 capsules of placebo
Outcomes	Primary outcome: CAPS Secondary outcomes: no information provided
Starting date	June 2005
Contact information	Contact: Joseph Zohar, MD: jzohar@post.tau.ac.il
Notes	Assessment of primary outcome at 1‐year follow‐up